NDC 25682-001
Soliris 300 mg per 30 mL injection, solution, concentrate
On the label: Alexion Pharmaceuticals Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Alexion Pharmaceuticals Inc. names for other drugs.
Recalls
- Jun 2, 2014 · Class I · Alexion Pharmaceuticals, Inc.
Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
Lots: Lots: 10002-1, 00006-1, Exp 08/14; 10003A, Exp 11/14; 10004A, Exp 02/15; 10005A, 10005AR, 10007A, 10006A, Exp 07/15; and 10008A, Exp 08/15 - Nov 4, 2013 · Class I · Alexion Pharmaceuticals, Inc.
Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.
Lots: Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Eculizumab: every company that makes it
- Form
- injection, solution, concentrate, intravenous
- Strength
- 300 mg per 30 mL
- Approval
- BLA BLA125166
- On the market since
- Apr 2, 2007
- Package NDCs
25682-001-01- Official label
- DailyMed (National Library of Medicine), updated Jul 8, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?